COMBINATION THERAPY COMPRISING A CCR5 ANTAGONIST, A HIV-1 PROTEASE INHIBITOR AND A PHARMACOKINETIC ENHANCER

• 收藏
• 分享

专利权人:

发明人:

TRESSLER RANDALL LEE U S A,VALDEZ HERNAN U S A

申请号：

IN3195/KOLNP/2012

公开号：

IN2012KN03195A

申请日:

2012.10.19

申请国别(地区):

IN

年份:

2013

代理人:

摘要：

The present invention discloses a novel combination therapy for HIV-1 treatment relying on a combination of at least one CCR5 antagonist, at least one HIV-1 protease inhibitor and at least one pharmacokinetic enhancer of said at least one CCR5 antagonist and/or at least one HIV-1 protease inhibitor. The combination is intended for use in oral treatment of a disorder selected from the group consisting of HIV-1 infection, retroviral infections genetically related to HIV and AIDS, in a treatmentnaive patient infected with CCR5 tropic HIV-1 virus.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/